Home > News > Company News > Gerresheimer Holds Its Wwn In Difficult Environment

Gerresheimer Holds Its Wwn In Difficult Environment

Post Time:Jul 17,2009Classify:Company NewsView:243

Sales in the first half of 2009 (excluding Technical Plastics) at prior year level
Growth in the pharma business
Sales decline in the cyclical segments of cosmetics and laboratory glassware
In the first half of 2009, Gerresheimer AG achieved sales at the prior year level despite the continuing worldwide economic crisis. This result was mainly attributable to sales growth for pharmaceutical packaging and systems, with which Gerresheimer today makes more than 70% of Group sales. In contrast, sales declines were recorded in the more cyclical segments of cosmetics and laboratory glassware. In comparison with the prior year, sales in the second quarter of 2009 declined by 4.3% on a nominal basis to €264.4m and, excluding the Technical Plastics business just sold, by 2.2% to €251.6m. The operating margin (adjusted EBITDA margin) excluding the business just sold reached a high level in the second quarter of 2009 at 18.9%. For the year as a whole, Gerresheimer expects the sales trend excluding Technical Plastics to be +1% to -3% with an adjusted EBITDA margin of 18.0% to 18.5%.
 
In the course of its continued focus on the markets of pharma & life science the sale of the Technical Plastics business was successfully completed as per July 1, 2009. The transaction price including debts taken over was around €12m.
 
“Growth in our core markets of pharma & life science has been and remains the basis of our profitable business development. This applies all the more at a time of economic crisis,” says Dr. Axel Herberg, CEO of Gerresheimer AG. “With the successful sale of the peripheral business of Technical Plastics we have taken another important step in focusing the business,” Herberg adds.
 
Growth for pharmaceutical products
 
Regardless of the continued trend towards inventory reductions by some pharma companies, Gerresheimer achieved sales growth with products for the pharma industry once again in the second quarter of 2009. Major contributions were made by Medical Plastic Systems, which continue to be a particular growth generator, and good sales of pharmaceutical primary packaging such as ampoules and vials in Europe and China. Installation of the third RTF® syringe line was completed according to plan so that customer-specific validations could be commenced.
 
As in the first quarter, however, continuing weak demand in the cosmetics segment led to a decline in sales of cosmetic packaging. A similar situation applies for laboratory glassware products, where a temporary sales decline was experienced because of inventory reductions and purchasing cautiousness by customers.
 
Outlook for 2009
 
Despite the imponderable factors with regard to further world economic development Gerresheimer continues to expect growth in the field of pharmaceutical packaging and systems. In the more cyclical segments cosmetics and laboratory glassware, Gerresheimer experienced a marked decline in demand in the first half year. Forecasts for the further course of the financial year are difficult. Gerresheimer AG does not however assume any short-term recovery of these markets. The sound balance sheet and long term financing structure as well as a good operating performance will enable Gerresheimer to continue the growth strategy in the pharma & life science segment going forward.
 
About Gerresheimer
 
Gerresheimer employs around 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2008, worldwide sales totaled €1.06bn. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterized by high technical and regulatory barriers.
 
Table.
 
Contact
Burkhard Lingenberg
Director Corporate Communication & Marketing
Telephone +49 211 6181-250
Telefax +49 211 6181-241

Source: Gerresheimer Author: shangyi

Related News

Hot News

返回顶部